top of page
Search

Out-of-pocket spending on insulin among people with private insurance

  • AAHC
  • Mar 23, 2022
  • 1 min read

Updated: Jul 17, 2022

Several legislative proposals in Congress propose a $35 per month cap on what people with health insurance would have to pay out of pocket for insulin, a life-saving hormone taken regularly by many people with diabetes to maintain their health.



This analysis of insurance claims data finds that such a cap could provide financial relief to at least 1 out of 5 insulin users with different types of private health insurance.


Among people with private insurance who currently pay more than $35 per month for insulin on average, half would save at least $19 per month, and a quarter would save at least $42 per month. Savings are highest among people who buy their own insurance.


The report analyzes 2018 claims data from the Centers for Medicare and Medicaid Services EDGE data for the individual and small-group markets and the IBM Health Analytics MarketScan Commercial Claims and Encounters Database for the large-employer market. It is available through the KFF-Peterson Health System Tracker, an online information hub dedicated to monitoring and assessing the performance of the U.S. health system.


CLICK HERE TO READ ARTICLE

 
 
 

Comments


Seal White-01.png

P.O. BOX #822 MONTGOMERY, AL 36101-0822

By providing your phone number and/or email, you are consenting to receive emails, calls, and SMS/MMS messages, including autodialed and automated calls and texts, to that number from Alliance of Alabama Healthcare Consumers. Message and data rates may apply. Message frequency may vary. Text STOP to opt-out or HELP for help. You can view our Privacy Policy and Mobile Terms of Service here.

bottom of page